Showing results 6 to 25 of 30
< previous
next >
| Issue Date | Title | Author(s) |
| 2017-09-02 | “Dicing and splicing” sphingosine kinase and relevance to cancer | Haddadi, N; Lin, Y; Simpson, AM; Nassif, NT; McGowan, EM |
| 2019-01-21 | Differential hepatic features presenting in Wilson disease-associated cirrhosis and hepatitis B-associated cirrhosis | Zhong, HJ; Sun, HH; Xue, LF; McGowan, EM; Chen, Y |
| 2017-09-12 | Effects of human mesenchymal stem cells on airway inflammation in allergic asthma mice and the underlying mechanism of actions | Ren, N; Chen, H; McGowan, EM; Chen, Q; An, J; Lin, Y |
| 2011-06-10 | Evaluation of cell cycle arrest in estrogen responsive MCF-7 breast cancer cells: Pitfalls of the MTS assay | McGowan, EM; Alling, N; Jackson, EA; Yagoub, D; Haass, NK; Allen, JD; Martinello-Wilks, R |
| 2022 | Expression Profile of Sphingosine Kinase 1 Isoforms in Human Cancer Tissues and Cells: Importance and Clinical Relevance of the Neglected 1b-Isoform. | Chen, H; Haddadi, N; Zhu, X; Hatoum, D; Chen, S; Nassif, NT; Lin, Y; McGowan, EM |
| 2018-05-05 | Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer | Boonyaratanakornkit, V; Hamilton, N; Márquez-Garbán, DC; Pateetin, P; McGowan, EM; Pietras, RJ |
| 2017-09-26 | FGFR1 lentivirus lung cancer cell model for anti-cancer drug discovery and the study of FGFR1 signaling pathway | Lin, Y; McGowan, EM; Xu, M |
| 2018-06-01 | Good guy or bad guy? The duality of wild-type p53 in hormone-dependent breast cancer origin, treatment, and recurrence | McGowan, EM; Lin, Y; Hatoum, D |
| 2015-01-01 | Hijacking of Endocrine and Metabolic Regulation in Cancer and Diabetes | McGowan, EM; Simpson, A; McManaman, J; Boonyaratanakornkit, V; Hardikar, AA |
| 2018-12-31 | An isomiR expression panel based novel breast cancer classification approach using improved mutual information | Lan, C; Peng, H; McGowan, EM; Hutvagner, G; Li, J |
| 2018-12-05 | An isomIR expression panel based novel breast cancer classification approach using improved mutual information | Lan, C; Peng, H; McGowan, EM; Hutvagner, G; Li, J |
| 2018-02-19 | Kinase-targeted cancer therapies: Progress, challenges and future directions | Bhullar, KS; Lagarón, NO; McGowan, EM; Parmar, I; Jha, A; Hubbard, BP; Rupasinghe, HPV |
| 2017-01-01 | Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: Challenges for SphK as an oncotarget | Hatoum, D; Haddadi, N; Lin, Y; Nassif, NT; McGowan, EM |
| 2018-07-03 | Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases | Chen, H; McGowan, EM; Ren, N; Lal, S; Nassif, N; Shad-Kaneez, F; Qu, X; Lin, Y |
| 2012-07-30 | P14ARF post-transcriptional regulation of nuclear cyclin D1 in MCF-7 breast cancer cells: Discrimination between a good and bad prognosis? | McGowan, EM; Tran, N; Alling, N; Yagoub, D; Sedger, LM; Martiniello-Wilks, R |
| 2021 | Progesterone Receptor Signaling in the Breast Tumor Microenvironment. | Boonyaratanakornkit, V; McGowan, EM; Márquez-Garbán, DC; Burton, LP; Hamilton, N; Pateetin, P; Pietras, RJ |
| 2023-10-12 | PTEN, PTENP1, microRNAs, and ceRNA Networks: Precision Targeting in Cancer Therapeutics. | Travis, G; McGowan, EM; Simpson, AM; Marsh, DJ; Nassif, NT |
| 2018-02-19 | PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy | Haddadi, N; Lin, Y; Travis, G; Simpson, AM; McGowan, EM; Nassif, NT |
| 2015-01-01 | Recent advances in the use of metformin: Can treating diabetes prevent breast cancer? | Hatoum, D; McGowan, EM |
| 2018-06-08 | The roles of p53 in mitochondrial dynamics and cancer metabolism: The pendulum between survival and death in breast cancer? | Moulder, DE; Hatoum, D; Tay, E; Lin, Y; McGowan, EM |
